Zero Xtreme Dietary Supplement 30-count capsules. By:Zero Xtreme Registro Sanitario No SD2014-0002208 LLC-USA
Published November 21, 2018 · Recall initiated: October 15, 2018
Summary
FDA records drug Class II recall D-0246-2019, published November 21, 2018 and initiated October 15, 2018. Recalling firm: Zero Xtreme USA; Status: Terminated; Reported quantity: 16 bottles; Lot: Lot: 1220062085 Exp. 03/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Zero Xtreme USA
- Distributor
- Nationwide within the USA.
- Lot
- Lot: 1220062085 Exp. 03/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMetoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJNovember 21, 2018
- FDAERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by:November 21, 2018
- FDATadalafil SR 12 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd'sNovember 21, 2018
- FDANitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDCNovember 21, 2018
- FDATadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd'sNovember 21, 2018
- FDAIsosorbide Dinitrate Tablets, USP 10 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJNovember 21, 2018
Questions about this recall
Was Zero Xtreme Dietary Supplement 30-count capsules. By:Zero Xtreme Registro Sanitario No SD2014-0002208 LLC-USA recalled?
Yes. FDA published recall D-0246-2019 on November 21, 2018. Reported hazard: Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine
What should I do if I have this product?
Voluntary: Firm initiated · Press Release